LexaGene (CVE:LXG) Trading Down 19.2% – Should You Sell?

LexaGene Holdings Inc. (CVE:LXG)’s stock price fell 19.2% during trading on Friday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares traded hands during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.

LexaGene Stock Down 19.2 %

The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13. The business’s fifty day moving average price is C$0.11 and its two-hundred day moving average price is C$0.11. The stock has a market capitalization of C$14.77 million, a PE ratio of -1.31 and a beta of 2.26.

LexaGene Company Profile

LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.